No association of SORL1 SNPs with Alzheimer's disease

Neuroscience Letters

Volumn 440, Issue 2, 2008, Pages 190-192

  Minster, Ryan L ^a   DeKosky, Steven T ^b   Kamboh, M Ilyas ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Genetics; SORL1

Indexed keywords

AMYLOID PROTEIN; PROTEIN SORL1;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALLELES; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HAPLOTYPES; HUMANS; LDL-RECEPTOR RELATED PROTEINS; MALE; MEMBRANE TRANSPORT PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; UNITED STATES; VARIATION (GENETICS);

EID: 45449085214     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.05.082     Document Type: Article

References (25)

1. Andersen O.M., Reiche J., Schmidt V., Gotthardt M., Spoelgen R., Behlke J., von Arnim C.A.F., Breiderhoff T., Jansen P., Wu X., Bales K.R., Cappai R., Masters C.L., Gliemann J., Mufson E.J., Hyman B.T., Paul S.M., Nykjær A., and Willnow T.E. Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 13461-13466 10.1073/pnas.0503689102
2. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Roses A.D., Haines J.L., and Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 (1993) 921-923 10.1126/science.8346443
3. Dupont W.D., and Plummer Jr. W.D. Power and sample size calculations for studies involving linear regression. Control. Clin. Trials 19 (1998) 589-601 10.1016/s0197-2456(98)00037-3
4. Gatz M., Reynolds C.A., Fratiglioni L., Johansson B., Mortimer J.A., Berg S., Fiske A., and Pedersen N.L. Role of genes and environments for explaining Alzheimer disease. Arch. Gen. Psychiatry 63 (2006) 168-174 10.1001/archpsyc.63.2.168
5. Kamboh M.I., Aston C.E., and Hamman R.F. The relationship of APOE polymorphism and cholesterol levels in normoglycemic and diabetic subjects in a biethnic population from the San Luis Valley, Colorado. Atherosclerosis 112 (1995) 145-159 10.1016/0021-9150(94)05409-c
6. Lee J.H., Cheng R., Schupf N., Manly J., Lantigua R., Stern Y., Rogaeva E., Wakutani Y., Farrer L., St George-Hyslop P., and Mayeux R. The association between genetic variants in SORL1 and Alzheimer disease in an urban, multiethnic, community-based cohort. Arch. Neurol. 64 (2007) 501-506 10.1001/archneur.64.4.501
7. Lee J.H., Chulikavit M., Pang D., Zigman W.B., Silverman W., and Schupf N. Association between genetics variants in sortilin-related receptor 1 (SORL1) and Alzheimer's disease in adults with Down syndrome. Neurosci. Lett. 425 (2007) 105-109 10.1016/j.neulet.2007.08.042
8. Li H., Wetten S., Li L., St Jean P.L., Upmanyu R., Surh L., Hosford D., Barnes M.R., Briley J.D., Borrie M., Coletta N., Delisle R., Dhalla D., Ehm M.G., Feldman H.H., Fornazzari L., Gauthier S., Goodgame N., Guzman D., Hammond S., Hollingworth P., Hsiung G.-Y., Johnson J., Kelly D.D., Keren R., Kertesz A., King K.S., Lovestone S., Loy-English I., Matthews P.M., Owen M.J., Plumpton M., Pryse-Phillips W., Prinjha R.K., Richardson J.C., Saunders A., Slater A.J., St George-Hyslop P.H., Stinnett S.W., Swartz J.E., Taylor R.L., Wherrett J., Williams J., Yarnall D.P., Gibson R.A., Irizarry M.C., Middleton L.T., and Roses A.D. Candidate single-nucleotide polymorphisms from a genomewide association study on Alzheimer disease. Arch. Neurol. 65 (2008) 45-53 10.1001/archneurol.2007.3
9. Li Y., Rowland C., Catanese J., Morris J., Lovestone S., O'Donovan M.C., Goate A., Owen M., Williams J., and Grupe A. SORL1 variants and risk of late-onset Alzheimer's disease. Neurobiol. Dis. 209 (2008) 293-296 10.1016/j.nbd.2007.09.001
10. Liu F., Arias-Vásquez A., Sleegers K., Aulchenko Y.S., Kayser M., Sanchez-Juan P., Feng B.-J., Bertoli-Avella A.M., van Swieten J., Axenovich T.I., Heutink P., van Broeckhoven C., Oostra B.A., and van Duijn C.M. A genomewide screen for late-onset Alzheimer disease in a genetically isolated Dutch population. Am. J. Hum. Genet. 81 (2007) 17-31 10.1086/518720
11. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
12. Meng Y., Lee J.H., Cheng R., St George-Hyslop P., Mayeux R., and Farrer L.A. Association between SORL1 and Alzheimer's disease in a genome-wide study. Neuroreport 18 (2007) 1761-1764 10.1097/wnr.0b013e3282f13e7a
13. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., van Belle G., and Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41 (1991) 479-486
14. National Institute on Aging. Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease, Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol. Aging 18 (1997) S1-S2 10.1016/s0197-4580(97)00057-2
15. Offe K., Dodson S.E., Shoemaker J.T., Fritz J.J., Gearing M., Levey A.I., and Lah J.J. The lipoprotein receptor LR11 regulates amyloid β production and amyloid precursor protein traffic in endosomal compartments. J. Neurosci. 26 (2006) 1596-1603 10.1523/jneurosci4946-052006
16. R Development Core Team, R: A language and environment for statistical computing, version 2.2.0. R Foundation for Statistical Computing, Vienna, Austria, 2005, www.r-project.org.
17. Reiman E.M., Webster J.A., Myers A.J., Hardy J., Dunckley T., Zismann V.L., Joshipura K.D., Pearson J.V., Hu-Lance D., Huentelman M.J., Craig D.W., Coon K.D., Liang W.S., Herbert R.H., Beach T., Rohrer K.C., Zhao A.S., Leung D., Bryden L., Marlowe L., Kaleem M., Mastroeni D., Grover A., Heward C.B., Ravid R., Rogers J., Hutton M.L., Melquist S., Petersen R.C., Alexander G.E., Caselli R.J., Kukull W., Papassotiropoulos A., and Stephan D.A. GAB2 alleles modify Alzheimer's risk in APOE ε4 carriers. Neuron 54 (2007) 713-720 10.1016/j.neuron.2007.05.022
18. Rogaeva E., Meng Y., Lee J.H., Gu Y., Kawarai T., Zou F., Katayama T., Baldwin C.T., Cheng R., Hasegawa H., Chen F., Shibata N., Lunetta K.L., Pardossi-Piquard R., Bohm C., Wakutani Y., Cupples L.A., Cuenco K.T., Green R.C., Pinessi L., Rainero I., Sorbi S., Bruni A., Duara R., Friedland R.P., Inzelberg R., Hampe W., Bujo H., Song Y.-Q., Andersen O.M., Willnow T.E., Graff-Radford N., Petersen R.C., Dickson D., Der S.D., Fraser P.E., Schmitt-Ulms G., Younkin S., Mayeux R., Farrer L.A., and St George-Hyslop P. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat. Genet. 39 (2007) 168-177 10.1038/ng1943
19. Scherzer C.R., Offe K., Gearing M., Rees H.D., Fang G., Heilman C.J., Schaller C., Bujo H., Levey A.I., and Lah J.J. Loss of apolipoprotein E receptor LR11 in Alzheimer disease. Arch. Neurol. 61 (2004) 1200-1205 10.1001/archneur.61.8.1200
20. Seshadri S., Drachman D.A., and Lippa C.F. Apolipoprotein E ε4 allele and the lifetime risk of Alzheimer's disease. What physicians know, and what they should know. Arch. Neurol. 52 (1995) 1074-1079
21. J.P. Sinnwell, D.J. Schaid, haplo.stats: Statistical Analysis of Haplotypes with Traits and Covariates when Linkage Phase is Ambiguous, R package version 1.2.2, 2005.
22. Slooter A.J.C., Cruts M., Kalmijn S., Hofman A., Breteler M.M.B., Van Broeckhoven C., and van Duijn C.M. Risk estimates of dementia by apolipoprotein E genotypes from a population-based study: the Rotterdam study. Arch. Neurol. 55 (1998) 964-968 10.1001/archneur.55.7.964
23. E.K. Tan, J. Lee, C.P. Chen, Y.Y. Teo, Y. Zhao, W.L. Lee. SORL1 haplotypes modulate risk of Alzheimer's disease in Chinese, Neurobiol. Aging, in press, doi:10.1016/j.neurobiolaging.2007.10.013.
24. G. Warnes, F. Leisch, Genetics: Population Genetics, R package version 1.2.0, 2005.
25. Webster J.A., Myers A.J., Pearson J.V., Craig D.W., Hu-Lince D., Coon K.D., Zismann V.L., Beach T., Leung D., Bryden L., Halperin R.F., Marlowe L., Kaleem M., Huentelman M.J., Joshipura K., Walker D., Heward C.B., Ravid R., Rogers J., Papassotiropoulos A., Hardy J., Reiman E.M., and Stephan D.A. Sorl1 as an Alzheimer's disease predisposition gene?. Neurodegen. Dis. 5 (2008) 60-64 10.1159/000110789